Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Barracchini

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tumori|June 13, 2001
High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA AnalyzerS D Adams, K C Barracchini, T B Simonis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
High-resolution HLA-A*0201 subtyping using directed heteroduplex analysisE J Kicklighter, K H Lee, K C Barracchini, et al.
The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.
Cancer Research|July 15, 1995
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytesL Rivoltini, K C Barracchini, V Viggiano, et al.
The Cancer Journal From Scientific American|October 1, 1996
Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashionR D Dadmarz, A Ordoubadi, A Mixon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.
Psychiatry Research|July 10, 1998
HLA antigens in childhood onset schizophreniaL K Jacobsen, B B Mittleman, S Kumra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tumori|June 13, 2001
High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA AnalyzerS D Adams, K C Barracchini, T B Simonis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
High-resolution HLA-A*0201 subtyping using directed heteroduplex analysisE J Kicklighter, K H Lee, K C Barracchini, et al.
The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.
Cancer Research|July 15, 1995
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytesL Rivoltini, K C Barracchini, V Viggiano, et al.
The Cancer Journal From Scientific American|October 1, 1996
Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashionR D Dadmarz, A Ordoubadi, A Mixon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.
Psychiatry Research|July 10, 1998
HLA antigens in childhood onset schizophreniaL K Jacobsen, B B Mittleman, S Kumra, et al.
Pageof 1